首页> 外文学位 >Development of molecular markers to distinguish Plasmodium vivax relapse from reinfection.
【24h】

Development of molecular markers to distinguish Plasmodium vivax relapse from reinfection.

机译:开发分子标志物以区分间日疟原虫复发与再感染。

获取原文
获取原文并翻译 | 示例

摘要

In areas with Plasmodium vivax transmission, malaria cases may represent primary infections or recurrent infections. Recurrent infections may be due to relapse (from hypnozoites), recrudescence (from persistent blood stages), or reinfection (from additional infectious mosquito bites). Because there are no clinical or parasitological criteria to distinguish among recurrent infections, a molecular strategy based on genetic polymorphic markers and the polymerase chain reaction (PCR) was developed to distinguish relapse from reinfection. Four sets of primers were designed and used in nested PCR to amplify polymorphic regions of P. vivax genes, including the fragments between Blocks 5 and 6, and Blocks 8 and 9 of the merozoite surface protein 1 (MSP1), the fragment between Regions I and II of the circumsporozoite protein (CSP), and a fragment between two conserved regions of the gametocyte blocking antigen 1 (GAM1). The combination of these four markers provided a sensitive system to characterize P. vivax and P. cynomolgi parasite types based on the pattern of their amplification products on agarose gel electrophoresis or amplicon length polymorphisms (ALPs).;The hypothesis that parasites which cause relapse are indistinguishable from those that caused the initial bloodstream infection was examined using the P. cynomolgi/rhesus monkey model of human P. vivax infection. Two rhesus monkeys were infected with sporozoites of P. c. bastianellii. PCR amplification products obtained from relapses were indistinguishable from each other and from the initial bloodstream infections in terms of size (MSP1 5/6 and 8/9, and CSP markers) and DNA sequence (MSP1 5/6 and CSP markers). Therefore, demonstrating the same parasite type in the initial infection and subsequent relapses.;Field studies were carried out in Colombia, South America, in collaboration with Corporacion CIDEIM (Centro Internacional de Entrenamiento e Investigaciones Medicas) located in Cali. The distribution of P. vivax parasite types was examined in endemic communities (Tumaco, Buenaventura, and the Oriental Plains) in order to estimate the probability of reinfection with the same parasite type. During the study period (March 1994 to October 1996), 339 filter paper blood samples from P. vivax infected patients were analyzed by PCR, including paired blood samples (initial bloodstream infection and subsequent recurrence) obtained from ten persons with recurrent infections. (Abstract shortened by UMI.)
机译:在间日疟原虫传播的地区,疟疾病例可能代表原发感染或反复感染。复发性感染可能是由于复发(来自子裂殖子),复发(由于持续的血液阶段)或再感染(由于其他传染性蚊虫叮咬)引起的。由于没有临床或寄生虫学标准来区分复发性感染,因此开发了基于遗传多态性标记和聚合酶链反应(PCR)的分子策略来区分复发和再感染。设计了四组引物,并用于巢式PCR中,以扩增间日疟原虫基因的多态性区域,包括裂殖子表面蛋白1(MSP1)的5和6嵌段,8和9的嵌段(I区之间的片段)和环子孢子蛋白(CSP)的第二个,以及配子阻断抗原1(GAM1)的两个保守区域之间的片段。这四种标记物的组合提供了一种敏感系统,可根据琼脂糖凝胶电泳或扩增子长度多态性(ALP)上扩增产物的模式来鉴定间日疟原虫和食蟹疟原虫的寄生虫类型。使用人类间日疟原虫感染的食蟹猴/恒河猴模型检查了与导致初次血液感染的那些没有区别的模型。两只恒河猴被P.c.的子孢子感染。巴斯蒂内利。从复发中获得的PCR扩增产物在大小(MSP1 5/6和8/9,以及CSP标记)和DNA序列(MSP1 5/6和CSP标记)方面与最初的血液感染没有区别。因此,在初次感染和随后的复发中证明了相同的寄生虫类型。与位于卡利的Corporacion CIDEIM(Centro Internacional de Entrenamiento e Investigaciones Medicas Medicas)合作在南美哥伦比亚进行了实地研究。在地方性社区(Tumaco,Buenaventura和Orientals Plains)检查了间日疟原虫寄生虫类型的分布,以估计再次感染同一寄生虫类型的可能性。在研究期间(1994年3月至1996年10月),通过PCR对来自间日疟原虫感染患者的339份滤纸血样进行了PCR分析,包括从十名反复感染者中获得的成对血样(初次血流感染和随后的复发)。 (摘要由UMI缩短。)

著录项

  • 作者

    Alger, Jackeline.;

  • 作者单位

    Tulane University.;

  • 授予单位 Tulane University.;
  • 学科 Biology Molecular.;Health Sciences Pathology.;Biology Microbiology.
  • 学位 Ph.D.
  • 年度 1997
  • 页码 135 p.
  • 总页数 135
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号